Main description:

Brain, Part 1 of The Netter Collection of Medical Illustrations: Nervous System, 2nd Edition, provides a highly visual guide to this complex organ, from basic neurodevelopment, neuroanatomy, neurophysiology, and cognition to classic disorders including to epilepsy, hypothalamus/pituitary with disorders of consciousness and sleep, movement disorders, cerebellum, stroke, multiple sclerosis, neurologic infections, neuro-oncology, headaches, and brain trauma. This spectacularly illustrated volume in the masterwork known as the (CIBA) Netter "Green Books" has been expanded and revised by Drs. H. Royden Jones, Jr., Ted M. Burns, Michael J. Aminoff, and Scott L. Pomeroy to mirror the many exciting advances in medicine and imaging - offering unparalleled insights into the broad clinical spectrum of brain disorders.

Get complete, integrated visual guidance on the brain with thorough, richly illustrated coverage.
Quickly understand complex topics thanks to a concise text-atlas format that provides a context bridge between primary and specialized medicine.
Clearly visualize how core concepts of anatomy, physiology, and other basic sciences correlate across disciplines.
Benefit from matchless Netter illustrations that offer precision, clarity, detail and realism as they provide a visual approach to the clinical presentation and care of the patient.

Gain a rich clinical view of all aspects of the brain in one comprehensive volume, conveyed through beautiful illustrations as well as up-to-date radiologic images.
Clearly see the connection between basic science and clinical practice with an integrated overview of normal structure and function as it relates to pathologic conditions.
Grasp current clinical concepts regarding development, pediatrics, and adult medicine captured in classic Netter illustrations, as well as new illustrations created specifically for this volume by artist-physician Carlos Machado, MD, and others working in the Netter style.

Contents:

SECTION 1-NORMAL AND ABNORMAL

DEVELOPMENT

1-1 Embryo at 18 Days, 2

1-2 Embryo at 20 to 24 Days, 3

1-3 Central Nervous System at 28 Days, 4

1-4 Central Nervous System at 36 Days, 5

1-5 Defective Neural Tube Formation, 6

1-6 Defective Neural Tube Formation

(Continued), 7

1-7 Spinal Dysraphism, 8

1-8 Spinal Dysraphism (Continued), 9

1-9 Fetal Brain Growth in the First

Trimester, 10

1-10 Craniosynostosis, 11

1-11 Extracranial Hemorrhage and Skull

Fractures in the Newborn, 12

1-12 Intracranial Hemorrhage in the

Newborn, 13

1-13 The External Development of the Brain

in the Second and Third Trimesters, 14

1-14 Mature Brain Ventricles, 15

1-15 Hydrocephalus, 16

1-16 Surgical Treatment of Hydrocephalus, 17

1-17 Cerebral Palsy, 18

1-18 Establishing Cellular Diversity in the

Embryonic Brain and Spinal Cord, 20

1-19 Generation of Neuronal Diversity in the

Spinal Cord and Hindbrain, 22

1-20 Circuit Formation in the Spinal Cord, 23

1-21 Sheath and Satellite Cell Formation, 24

1-22 Development of Myelination and Axon

Ensheathment, 25

1-23 Brachial Plexus and/or Cervical Nerve

Root Injuries at Birth, 26

1-24 Morphogenesis and Regional

Differentiation of the Forebrain, 27

1-25 Neurogenesis and Cell Migration in the

Developing Neocortex, 28

1-26 Neuronal Proliferation and Migration

Disorders, 29

1-27 Developmental Dyslexia, 30

1-28 Autism Spectrum Disorders, 31

1-29 Rett Syndrome, 32

SECTION 2-CEREBRAL CORTEX AND

NEUROCOGNITIVE DISORDERS

2-1 Superolateral Surface of Brain, 34

2-2 Medial Surface of Brain, 35

2-3 Inferior Surface of Brain, 36

2-4 Cerebral Cortex: Function and

Association Pathways, 37

2-5 Major Cortical Association Bundles, 38

2-6 Corticocortical and Subcorticocortical

Projection Circuits, 39

2-7 Corpus Callosum, 40

2-8 Rhinencephalon and Limbic System, 41

2-9 Hippocampus, 42

2-10 Fornix, 43

2-11 Amygdala, 44

2-12 Forebrain Regions Associated with

Hypothalamus, 45

2-13 Thalamocortical Radiations, 46

2-14 Neuronal Structure and Synapses, 47

2-15 Chemical Synaptic Transmission, 48

2-16 Summation of Excitation and

Inhibition, 49

2-17 Types of Neurons in Cerebral Cortex, 50

2-18 Astrocytes, 51

2-19 Testing for Defects of Higher Cortical

Function, 52

2-20 Memory Circuits, 53

2-21 Amnesia, 54

2-22 Dominant Hemisphere Language

Dysfunction, 55

2-23 Nondominant Hemisphere Higher Cortical

Dysfunction, 56

2-24 Alzheimer Disease: Pathology, 57

2-25 Alzheimer Disease: Distribution of

Pathology, 58

2-26 Alzheimer Disease: Clinical

Manifestations, Progressive Phases, 59

2-27 Frontotemporal Dementia, 60

2-28 Dementia with Lewy Bodies, 61

2-29 Vascular Dementia, 62

2-30 Treatable Dementias, 63

2-31 Normal-Pressure Hydrocephalus, 64

SECTION 3-EPILEPSY

3-1 Electroencephalography, 66

3-2 Focal (Partial) Seizures, 67

3-3 Generalized Tonic-Clonic Seizures, 68

3-4 Absence Seizures, 69

3-5 Epileptic Syndromes, 70

3-6 Neonatal Seizures, 71

3-7 Status Epilepticus, 72

3-8 Causes of Seizures, 73

3-9 Neurobiology of Epilepsy, 74

3-10 Neurobiology of Epilepsy (Continued), 75

3-11 Neurobiology of Epilepsy (Continued), 76

3-12 Treatment of Epilepsy: Preoperative

Evaluation, 77

3-13 Treatment of Epilepsy: Resective

Surgery, 78

SECTION 4-PSYCHIATRY

4-1 Limbic System, 80

4-2 Major Depressive Disorder, 81

4-3 Postpartum Depression, 82

4-4 Bipolar Disorder, 83

4-5 Generalized Anxiety Disorder, 84

4-6 Social Anxiety disorder, 85

4-7 Panic Disorder, 86

4-8 Posttraumatic Stress Disorder, 87

4-9 Obsessive-Compulsive Disorder, 88

4-10 Somatization, 89

4-11 Conversion Disorder, 90

4-12 Schizophrenia, 91

4-13 Alcohol Use Disorders, 92

4-14 Treatment for Alcohol Use Disorders, 93

4-15 Alcohol Withdrawal, 94

4-16 Opioid Use Disorders, 95

4-17 Opioid Withdrawal, 96

4-18 Borderline Personality Disorder, 97

4-19 Antisocial Personality Disorder, 98

4-20 Intimate Partner Abuse, 99

4-21 Elder Abuse, 100

4-22 Delirium and Acute Personality

Changes, 101

4-23 Delirium and Acute Personality Changes

(Continued), 102

4-24 Insomnia, 103

4-25 Pediatrics: Depressive Disorders, 104

4-26 Pediatrics: Anxiety Disorders, 105

4-27 Pediatrics: Disruptive Behavior

Disorders, 106

4-28 Pediatrics: Attention-Deficit/Hyperactivity

Disorder, 107

4-29 Pediatrics: Eating Disorders, 108

4-30 Child Abuse: Fractures in Abused

Children, 109

4-31 Child Abuse: Staging of Injuries and

Injury Patterns, 110

SECTION 5-HYPOTHALAMUS, PITUITARY,

SLEEP, AND THALAMUS

5-1 Anatomic Relationships of the

Hypothalamus, 112

5-2 Development and Developmental

Disorders of the Hypothalamus, 113

5-3 Blood Supply of the Hypothalamus and

Pituitary Gland, 114

5-4 General Topography of the

Hypothalamus, 115

5-5 Overview of Hypothalamic Nuclei, 116

5-6 Hypothalamic Control of the Pituitary

Gland, 117

5-7 Hypothalamic Control of the Autonomic

Nervous System, 118

5-8 Olfactory Inputs to the

Hypothalamus, 119

5-9 Visual Inputs to the Hypothalamus, 120

5-10 Somatosensory Inputs to the

Hypothalamus, 121

5-11 Taste and Other Visceral Sensory Inputs

to the Hypothalamus, 122

5-12 Limbic and Cortical Inputs to the

Hypothalamus, 123

5-13 Overview of Hypothalamic Function and

Dysfunction, 124

5-14 Regulation of Water Balance, 125

5-15 Temperature Regulation, 126

5-16 Fever: Cytokines and Prostaglandins

Cause the Sickness Response, 127

5-17 Fever: Hypothalamic Responses During

Inflammation Modulate Immune

Response, 128

5-18 Regulation of Food Intake, Body Weight,

and Metabolism, 129

5-19 Stress Response, 130

5-20 Hypothalamic Regulation of

Cardiovascular Function, 131

5-21 Hypothalamic Regulation of Sleep, 132

5-22 Narcolepsy: A Hypothalamic Sleep

Disorder, 133

5-23 Sleep-Disordered Breathing, 134

5-24 Parasomnias, 135

5-25 Divisions of the Pituitary Gland

and Its Relationships to the

Hypothalamus, 136

5-26 Posterior Pituitary Gland, 137

5-27 Anatomic Relationships of the Pituitary

Gland, 138

5-28 Effects of Pituitary Mass Lesions on the

Visual Apparatus, 139

5-29 Anterior Pituitary Hormone

Deficiencies, 140

5-30 Severe Anterior Pituitary Hormone

Deficiencies (Panhypopituitarism), 141

5-31 Postpartum Pituitary Infarction (Sheehan

Syndrome), 142

5-32 Pituitary Apoplexy, 143

5-33 Thalamic Anatomy and Pathology, 144

5-34 Thalamic Anatomy and Pathology

(Continued), 145

SECTION 6-DISORDERS OF

CONSCIOUSNESS (COMA)

6-1 Coma, 148

6-2 Disorders of Consciousness, 149

6-3 Full Outline of Unresponsiveness Score

(FOUR), 150

6-4 Prognosis in Coma Related to Severe

Head Injuries, 151

6-5 Differential Diagnosis of Coma, 152

6-6 Hypoxic-Ischemic Brain Damage, 153

6-7 Vegetative State and Minimally Conscious

State, 154

6-8 Brain Death, 155

6-9 Ventilatory Patterns and Apnea Test, 156

SECTION 7-BASAL GANGLIA AND

MOVEMENT DISORDERS

7-1 Basal Nuclei (Ganglia), 158

7-2 Basal Ganglia and Related Structures 159

7-3 Schematic and Cross Section of Basal

Ganglia, 160

7-4 Parkinsonism: Early Manifestations, 161

7-5 Parkinsonism: Successive Clinical

Stages, 162

7-6 Neuropathology of Parkinson

Disease, 163

7-7 Progressive Supranuclear Palsy, 164

7-8 Corticobasal Degeneration, 165

7-9 Parkinsonism: Hypothesized Role of

Dopamine, 166

7-10 Surgical Management of Movement

Disorders, 167

7-11 Hyperkinetic Movement Disorder:

Idiopathic Torsion Dystonia, 168

7-12 Hyperkinetic Movement Disorder:

Cervical Dystonia, 169

7-13 Chorea/Ballism, 170

7-14 Tremor, 171

7-15 Tics and Tourette Syndrome, 172

7-16 Myoclonus, 173

7-17 Wilson Disease, 174

7-18 Psychogenic Movement Disorders, 175

7-19 Cerebral Palsy, 176

SECTION 8-CEREBELLUM AND ATAXIA

8-1 Cerebellum and the Fourth Ventricle, 178

8-2 Cerebellum Gross Anatomy, 179

8-3 Cerebellar Peduncles, 180

8-4 Cerebellar Cortex and Nuclei, 181

8-5 Cerebellar Cortex and Nuclei

(Continued), 182

8-6 Cerebellar Cortical and Corticonuclear

Circuitry, 183

8-7 Cerebellar Cortical and Corticonuclear

Circuitry (Continued), 184

8-8 Cerebellum Subdivisions and Afferent

Pathways, 185

8-9 Cerebellum Subdivisions and Afferent

Pathways (Continued), 186

8-10 Cerebellar Efferent Pathways, 187

8-11 Cerebellovestibular Pathways, 189

8-12 Cerebellum Modular Organization, 190

8-13 Cerebrocerebellar Connections, 191

8-14 Cerebellar Motor Examination, 192

8-15 Cerebellar Cognitive Affective

Syndrome, 193

8-16 Cerebellar Disorders Differential

Diagnosis, 194

8-17 Gait Disorders-Differential

Diagnosis, 195

8-18 Gait Disorders-Differential Diagnosis

(Continued), 196

8-19 Friedreich Ataxia, 197

SECTION 9-CEREBROVASCULAR

CIRCULATION AND STROKE

OVERVIEW AND APPROACH TO STROKE PATIENT

9-1 Arteries to Brain and Meninges, 200

9-2 Territories of the Cerebral Arteries, 201

9-3 Arteries of Brain: Lateral and Medial

Views, 202

9-4 Arteries Of Brain: Frontal View and

Section, 203

9-5 Stroke Subtypes, 204

9-6 Temporal Profile of Transient Ischemic

Attack (TIA) and Completed Infarction

(CI), 205

9-7 Clinical Evaluation and Therapeutic

Options in Stroke, 206

9-8 Clinical Evaluation and Therapeutic

Options in Stroke (Continued), 207

9-9 Uncommon Etiologic Mechanisms in

Stroke, 208

ANTERIOR CIRCULATION ISCHEMIA

9-10 Common Sites of Cerebrovascular

Occlusive Disease, 209

9-11 Other Etiologies of Carotid Artery

Disease, 210

9-12 Clinical Manifestations of Carotid Artery

Disease, 211

9-13 Occlusion of Middle and Anterior

Cerebral Arteries, 212

9-14 Diagnosis of Internal Carotid

Disease, 213

9-15 Diagnosis of Carotid Artery Disease, 214

9-16 Carotid Endarterectomy, 215

9-17 Endovascular ICA Angioplasty and

Stenting Using A Protective Device, 216

VERTEBRAL BASILAR SYSTEM DISORDERS

9-18 Arterial Distribution to the Brain: Basal

View, 217

9-19 Arteries of Posterior Cranial Fossa, 218

9-20 Clinical Manifestations of Vertebrobasilar

Territory Ischemia, 219

9-21 Intracranial Occlusion of Vertebral

Artery, 220

9-22 Occlusion of Basilar Artery and

Branches, 221

9-23 Occlusion of "Top of Basilar" and

Posterior Cerebral Arteries, 222

BRAIN EMBOLI

9-24 Cardiac Sources of Brain Emboli, 223

9-25 Uncommon Cardiac Mechanisms In

Stroke, 224

LACUNAR STROKE

9-26 Lacunar Infarction, 225

9-27 Risk Factors for Cardiovascular

Disease, 226

OTHER

9-28 Hypertensive Encephalopathy, 227

9-29 Hypoxia, 228

COAGULOPATHIES

9-30 Role of Platelets in Arterial

Thrombosis, 229

9-31 Inherited Thrombophilias, 230

9-32 Antiphospholipid Antibody

Syndrome, 231

VENOUS SINUS THROMBOSIS

9-33 Meninges and Superficial Cerebral

Veins, 232

9-34 Intracranial Venous Sinuses, 233

9-35 Diagnosis of Venous Sinus

Thrombosis, 234

INTRACEREBRAL HEMORRHAGE

9-36 Pathogenesis and Types, 235

9-37 Clinical Manifestations of Intracranial

Hemorrhage Related to Site, 236

9-38 Vascular Malformations, 237

SUBARACHNOID HEMORRHAGE AND

INTRACRANIAL ANEURYSMS

9-39 Distribution and Clinical Manifestations

of Congenital Aneurysm Rupture, 238

9-40 Giant Congenital Aneurysms, 239

9-41 Ophthalmologic Manifestations of

Cerebral Aneurysms, 240

9-42 Approach to Internal Carotid

Aneurysms, 241

9-43 Interventional Radiologic Repair of Berry

Aneurysms, 242

PEDIATRICS

9-44 Pediatric Cerebrovascular Disease, 243

REHABILITATION

9-45 Positioning in Bed and Passive

Range-of-Motion Exercises After

Stroke, 244

9-46 Aphasia Rehabilitation, 245

9-47 Other Rehabilitative Issues: Dysphagia/

Gait Training/Locked-in Syndrome, 246

SECTION 10-MULTIPLE SCLEROSIS AND

OTHER CENTRAL NERVOUS SYSTEM

AUTOIMMUNE DISORDERS

MULTIPLE SCLEROSIS

10-1 Overview, 248

10-2 Clinical Manifestations, 249

10-3 Diagnosis, 250

10-4 Diagnosis: Spinal Cord MRI in Multiple

Sclerosis, 251

10-5 Diagnosis: Visual Evoked Response and

Spinal Fluid Analysis, 252

10-6 MS Pathophysiology, 253

10-7 MS Pathophysiology (Continued), 254

10-8 MS Relapses, 256

10-9 MS Relapses (Continued), 257

10-10 MS Relapses (Continued), 258

10-11 MS Relapses: Consequences, 259

10-12 Enigma of Progressive MS, 260

10-13 MS Pathology, 261

10-14 MS Treatment, 262

NEUROIMMUNOLOGIC SYNDROMES

10-15 Neuromyelitis Optica, Acute

Disseminated Encephalomyelitis, and

Acute Hemorrhagic Leukoencephalitis

-Radiologic Findings, 264

10-16 Neuromyelitis Optica, Acute

Disseminated Encephalomyelitis, and

Acute Hemorrhagic Leukoencephalitis-

Histopathologic Findings, 265

10-17 Other Neuroimmunologic Syndromes:

an Overlap Between Primary and

Paraneoplastic Processes, 266

10-18 Stiff-Man Syndrome, 267

10-19 Paraneoplastic Immune-Mediated

Disorders, 268

10-20 Paraneoplastic Immune-Mediated

Disorders (Continued), 269

10-21 Neuroimmunology: Paraneoplastic and

Other Autoimmune Syndromes-Central

Nervous System, 270

10-22 Neuroimmunology: Paraneoplastic and

Other Autoimmune Syndromes-

Peripheral Motor Sensory Unit, 271

SECTION 11-INFECTIONS OF

THE NERVOUS SYSTEM

11-1 Bacterial Meningitis, 274

11-2 Bacterial Meningitis (Continued), 275

11-3 Brain Abscess, 276

11-4 Parameningeal Infections, 277

11-5 Infections in the Immunocompromised

Host: Progressive Multifocal

Leukoencephalopathy and

Nocardiosis, 278

11-6 Infections in the Immunocompromised

Host: Listeriosis and Toxoplasmosis, 279

11-7 Neurocysticercosis, 280

11-8 Spirochetal Infections: Neurosyphilis, 281

11-9 Spirochetal Infections: Lyme

Disease, 282

11-10 Tuberculosis of Brain and Spine, 283

11-11 Tetanus, 284

11-12 Aseptic Meningitis, 285

11-13 Primary HIV Infection of the Nervous

System, 286

11-14 HIV Life Cycle and Antiretroviral

Medications, 287

11-15 Poliomyelitis, 288

11-16 Herpes Zoster, 289

11-17 Herpes Simplex Virus Encephalitis and

Rabies, 290

11-18 Cerebral Malaria and African

Trypanosomiasis, 291

11-19 Trichinosis (Trichinellosis), 292

11-20 Cryptococcal Meningitis, 293

11-21 Creutzfeldt-Jakob Disease, 294

11-22 Neurosarcoidosis, 295

SECTION 12-NEURO-ONCOLOGY

12-1 Clinical Presentations of Brain

Tumors, 298

12-2 Gliomas, 299

12-3 Glioblastoma, 300

12-4 Pediatric Brain Tumors, 301

12-5 Pediatric Brain Tumors (Continued), 302

12-6 Metastatic Tumors to Brain, 303

12-7 Meningiomas, 304

12-8 Meningiomas (Continued), 305

12-9 Pituitary Tumors, 306

12-10 Clinically Nonfunctioning Pituitary

Tumor, 307

12-11 Craniopharyngioma, 308

12-12 Tumors of Pineal Region, 309

12-13 Vestibular Schwannomas, 310

12-14 Removal of Vestibular Schwannoma, 311

12-15 Intraventricular Tumors, 312

12-16 Chordomas, 313

12-17 Differential Diagnosis of CNS

Tumors, 314

12-18 Treatment Modalities, 315

SECTION 13-HEADACHE

13-1 Overview of Headaches, 318

13-2 Migraine Pathophysiology, 319

13-3 Migraine Presentation, 320

13-4 Migraine Aura, 321

13-5 Migraine Management, 322

13-6 Trigeminal Autonomic Cephalagias:

Cluster Headache, 323

13-7 Trigeminal Autonomic Cephalagias:

Paroxysmal Hemicrania (PH), 324

13-8 Tension-Type Headache and Other

Benign Episodic and Chronic

Headaches, 325

13-9 Pediatric Headache, 326

13-10 Cranial Neuralgias-Trigeminal

Neuralgia, 327

13-11 Other Cranial Neuralgias, 328

13-12 Idiopathic Intracranial Hypertension (IIH),

Pseudotumor Cerebri, 329

13-13 Intracranial Hypotension/ Low

Cerebrospinal Fluid Pressure

Headache, 330

13-14 Giant Cell Arteritis, 331

13-15 Contiguous Structure Headaches, 332

13-16 Thunderclap Headache and Other

Headaches Presenting in the Emergency

Department, 333

13-17 Headaches Presenting in the Emergency

Department (Continued), 334

13-18 Headaches Presenting in the Emergency

Department (Continued), 335

13-19 Headaches Presenting in the Emergency

Department (Continued), 336

SECTION 14-HEAD TRAUMA

14-1 Skull: Anterior View, 338

14-2 Skull: Lateral View, 339

14-3 Skull: Midsagittal Section, 340

14-4 Calvaria, 341

14-5 External Aspect of Skull Base, 342

14-6 Internal Aspects of Base of Skull:

Bones, 343

14-7 Internal Aspects of Base of Skull:

Orifices, 344

14-8 Skull Injuries, 345

14-9 Concussion, 346

14-10 Acute Epidural Hematoma, 347

14-11 Acute Subdural Hematoma, 348

14-12 CT Scans and MR Images of Intracranial

Hematomas, 349

14-13 Vascular Injury, 350

14-14 Initial Assessment and Management of

Head Injury, 351

14-15 Glasgow Coma Score, 352

14-16 Neurocritical Care and Management

after Traumatic Brain Injury: Devices

for Monitoring Intracranial

Pressure, 353

14-17 Neurocritical Care and Management:

Decompressive Craniectomy, 354